Fetal tachycardia associated with intrauterine fetal thyrotoxicosis.
Tachycardia in both fetuses of a twin gestation was documented in a mother who had undergone subtotal thyroidectomy 8 years prior to her present pregnancy. Maternal and fetal plasma concentrations of long-acting thyroid stimulator (LATS) and amniotic fluid 3,3',5'-triiodothyronine (reverse T3) were determined. All values were consistent with the diagnosis of fetal thyrotoxicosis, as were cord blood studies performed on the fetuses post partum. Significant concentrations of LATS were present in fetal cord blood. The first fetus survived but suffered hyperthyroidism during the first 3 neonatal weeks. The second twin died, possibly of fetal thyrotoxicosis. These studies suggest that in women with a history of thyrotoxicosis, high levels of maternal LATS may in some instances provoke fetal thyrotoxicosis, which can be diagnosed by the measurement of amniotic fluid reverse T3.
D000328:Adult; D000653:Amniotic Fluid / Q000032:analysis; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis*; D005318:Fetal Heart; D006801:Humans; D006980:Hyperthyroidism / Q000175:diagnosis*; D007231:Infant, Newborn; D008135:Long-Acting Thyroid Stimulator / Q000097:blood; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications; D011272:Pregnancy, Multiple; D013610:Tachycardia / Q000175:diagnosis*; D014285:Triiodothyronine, Reverse / Q000032:analysis; D014427:Twins
D014285:Triiodothyronine, Reverse; D008135:Long-Acting Thyroid Stimulator